CD4 and gastric cancer: In addition, the Cox proportional hazard model showed that CD4+ T cell (p = 0.04), macrophage (p = 0.013), and SFRP5 expression (p = 0.048) were significantly associated with clinical outcomes in GC patients (Table 2).